{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:21:27Z","timestamp":1790770887821,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"NIDCR","doi-asserted-by":"crossref","award":["DE013207"],"award-info":[{"award-number":["DE013207"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000072","name":"NIDCR","doi-asserted-by":"crossref","award":["AR060055"],"award-info":[{"award-number":["AR060055"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jconrel.2013.06.024","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T14:45:38Z","timestamp":1372689938000},"page":"33-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Locally delivered salicylic acid from a poly(anhydride-ester): Impact on diabetic bone regeneration"],"prefix":"10.1016","volume":"171","author":[{"given":"Keisuke","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Elazizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Ouimet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselin","family":"Rosario-Mel\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Fiorellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana T.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Uhrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2013.06.024_bb0005","series-title":"Diabetes Facts Sheet","author":"American Diabetes Association","year":"2011"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0010","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2741\/2757","article-title":"Diabetic complications and dysregulated innate immunity","volume":"13","author":"Graves","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0015","first-page":"939751","article-title":"Role of forkhead transcription factors in diabetes-induced oxidative stress","author":"Ponugoti","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0020","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1185\/03007990902801147","article-title":"Bone health in diabetes: considerations for clinical management","volume":"25","author":"Adami","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2012.1","article-title":"Fracture healing under healthy and inflammatory conditions","volume":"8","author":"Claes","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/en.2002-220072","article-title":"Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation","volume":"144","author":"Lu","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0035","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1096\/fj.11-196279","article-title":"Diabetes aggravates periodontitis by limiting repair through enhanced inflammation","volume":"26","author":"Pacios","year":"2012","journal-title":"FASEB"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0040","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jacc.2005.06.007","article-title":"Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease","volume":"46","author":"Sasso","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0045","first-page":"611","article-title":"Increased expression of the receptor for activation of NF-kappaB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocin-induced diabetes","volume":"26","author":"Hie","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0050","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1359\/jbmr.070115","article-title":"Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity","volume":"22","author":"Kayal","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0055","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/154405910608500606","article-title":"Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation","volume":"85","author":"Liu","year":"2006","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.surge.2012.04.001","article-title":"Bone graft substitutes: what are the options?","volume":"10","author":"Dinopoulos","year":"2012","journal-title":"Surgeon"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000337666","article-title":"Alveolar bone grafting","volume":"169","author":"Semb","year":"2012","journal-title":"Front. Oral Biol."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0501.2009.01805.x","article-title":"Effect of diabetes and metabolic control on de novo bone formation following guided bone regeneration","volume":"21","author":"Retzepi","year":"2010","journal-title":"Clin. Oral Implants Res."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cpm.2012.07.005","article-title":"An overview of bone grafting techniques for the diabetic Charcot foot and ankle","volume":"29","author":"Ramanujam","year":"2012","journal-title":"Clin. Podiatr. Med. Surg."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0080","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00264-007-0422-x","article-title":"Clinical applications of BMP-7\/OP-1 in fractures, nonunions and spinal fusion","volume":"31","author":"White","year":"2007","journal-title":"Int. Orthop."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0085","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1902\/jop.2005.76.4.605","article-title":"Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation","volume":"76","author":"Fiorellini","year":"2005","journal-title":"J. Periodontol."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0090","doi-asserted-by":"crossref","DOI":"10.3171\/foc.2002.13.6.5","article-title":"Use of osteogenic protein-1 in spinal fusion: literature review and preliminary results in a prospective series of high-risk cases","volume":"13","author":"Govender","year":"2002","journal-title":"Neurosurg. Focus."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11300","article-title":"Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review","volume":"11","author":"Garrison","year":"2007","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0100","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0142-9612(00)00073-9","article-title":"Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters)","volume":"21","author":"Erdmann","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/bm049544+","article-title":"Synthesis and cytotoxicity of salicylate-based poly(anhydride esters)","volume":"6","author":"Schmeltzer","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0110","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0142-9612(00)00118-6","article-title":"Degradable poly(anhydride ester) implants: effects of localized salicylic acid release on bone","volume":"21","author":"Erdmann","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/cyto.1998.0437","article-title":"Non-steroidal anti-inflammatory drugs inhibit the expression of cytokines and induce HSP70 in human monocytes","volume":"11","author":"Housby","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0952-3278(03)00027-9","article-title":"Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells","volume":"68","author":"Fujita","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0125","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S8756-3282(02)00697-X","article-title":"Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin\/RANKL-dependent mechanism","volume":"30","author":"Gruber","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0130","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1210\/endo.139.7.6085","article-title":"Prostaglandin E2, interleukin 1 alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro","volume":"139","author":"Lader","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0135","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI8195","article-title":"Prostaglandin G\/H synthase-2 is required for maximal formation of osteoclast-like cells in culture","volume":"105","author":"Okada","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00289-003-0123-6","article-title":"Optimized synthesis of salicylate-based poly(anhydride-esters)","volume":"49","author":"Schmeltzer","year":"2003","journal-title":"Polym. Bull."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0145","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jbm.a.30356","article-title":"Investigation into the erosion mechanism of salicylate-based poly(anhydride-esters)","volume":"76","author":"Whitaker-Brothers","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0150","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0169-409X(02)00051-0","article-title":"Polyanhydride degradation and erosion","volume":"54","author":"G\u00f6pferich","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0155","first-page":"437","article-title":"Reactive oxygen species as cellular messengers","volume":"2","author":"Khan","year":"1995","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0160","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.injury.2005.07.019","article-title":"Current concepts of molecular aspects of bone healing","volume":"36","author":"Dimitriou","year":"2005","journal-title":"Int. J. Care Inj."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0165","first-page":"89","article-title":"Inflammation and the mechanism of action of anti-inflammatory drugs","volume":"1","author":"Vane","year":"1987","journal-title":"J. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0170","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/endo.141.4.7405","article-title":"The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs","volume":"141","author":"Suzawa","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1097-4652(199806)175:3<247::AID-JCP2>3.0.CO;2-O","article-title":"Suppression of interleukin-11-mediated bone resorption by cyclooxygenases inhibitors","volume":"175","author":"Morinaga","year":"1998","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0180","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S8756-3282(97)00147-6","article-title":"The in vivo anabolic actions of prostaglandins in bone","volume":"21","author":"Jee","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0185","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tem.2009.12.004","article-title":"Prostaglandins in bone: bad cop, good cop?","volume":"21","author":"Blackwell","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0190","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00003086-198511000-00019","article-title":"Fracture healing perspectives","volume":"200","author":"Simmons","year":"1985","journal-title":"Clin. Orthop."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/156720107781023866","article-title":"Non-steroidal anti-inflammatory drug (NSAID)-derived poly(anhydride-esters) in bone and periodontal regeneration","volume":"4","author":"Reynolds","year":"2007","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0200","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0142-9612(00)00118-6","article-title":"Degradable poly(anhydride ester) implants: effects of localized salicylic acid release on bone","volume":"21","author":"Erdmann","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2013.06.024_bb0205","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jbm.a.30184","article-title":"Salicylic acid-derived poly(anhydride-esters) inhibit bone resorption and formation in vivo","volume":"72A","author":"Harten","year":"2005","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2013.06.024_bb0210","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/ph3051668","article-title":"Effect of non-steroidal anti-inflammatory drugs on bone healing","volume":"3","author":"Cottrell","year":"2010","journal-title":"Pharmaceuticals"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T23:21:47Z","timestamp":1645917707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913003714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0168365913003714"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.06.024","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Locally delivered salicylic acid from a poly(anhydride-ester): Impact on diabetic bone regeneration","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}